NCT06605443 Precision Medicine for L/GCMN and Melanoma 2
| NCT ID | NCT06605443 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundacion Clinic per a la Recerca Biomédica |
| Condition | Melanoma (Skin Cancer) |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-01-01 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective is to evaluate the possibility of using minimally and non-invasive technologies (skin patch and breath analyzer) based on the detection of volatile organic compounds (VOCs) for the early identification of metastases. The secondary objective is to evaluate the usability of these technologies in the follow up of high-risk melanoma patients.
Eligibility Criteria
Inclusion Criteria: * Be over 18 years old * Have a histopathological confirmed melanoma diagnosis (stage II, III or IV AJCC) Exclusion Criteria: * Not signing the informed consent form * Present other cancers or chronic diseases (such as diabetes, asthma, etc.), which may affect the volatile organic compound profiles
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06605443 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Melanoma (Skin Cancer). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06605443 currently recruiting?
Yes, NCT06605443 is actively recruiting participants. Contact the research team at spuig@clinic.cat for enrollment information.
Where is the NCT06605443 trial being conducted?
This trial is being conducted at Barcelona, Spain, Barcelona, Spain, Barcelona, Spain.
Who is sponsoring the NCT06605443 clinical trial?
NCT06605443 is sponsored by Fundacion Clinic per a la Recerca Biomédica. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.